Moreover, FDA is proposing two other constraints about the submission of the supplemental PMTA. Below proposed § 1114.15(a), a supplemental PMTA couldn't be submitted exactly where the advertising buy for the first tobacco product has become withdrawn or has long been quickly suspended or is the sub